Additional file 2, comprised of Figures S1-S8 Fig. S4 ; however, one can see dynamic changes over time, as more factors become involved in each network. D) Additional downstream target nodal network for the predicted mouse (host) upstream regulator Ifnar, showing engagement of numerous immunogenic death pathways, such as interferon, tumor necrosis factor, and MHC signaling, by metronomic CPA treatment at the late time points across both models, i.e., U251 tumors
Fig. S3
-PPARG gene network, as determined by IPA network analysis. IPA was used to elucidate important nodal connections between a suspected tumor cell-specific regulator, and ultimate cell death determination, potentially including immune activation through interleukin, cathepsin, as well as STAT and interferon-related signaling. Deeper shades of red indicate stronger up regulation of the gene by metronomic CPA treatment. Fig. S4 ; however, one can see dynamic changes over time, as more factors become involved in each network. D) Additional downstream target nodal network for the predicted mouse (host) upstream regulator Ifnar, showing engagement of numerous immunogenic death pathways, such as interferon, tumor necrosis factor, and MHC signaling, by metronomic CPA treatment at the late time points across both models, i.e., U251 tumors on day 18 U251 and 9L tumors on day 24. E) IPA-predicted upstream regulator interferon gamma, IFNG, target molecule network, with cellular compartmentalization, from the mouse array, in response to metronomic CPA across both models at the late time points. 
